Description
/* Reset & Base */
* {
box-sizing: border-box;
margin: 0;
padding: 0;
}
body {
font-family: ‘Inter’, -apple-system, BlinkMacSystemFont, ‘Segoe UI’, Roboto, Helvetica, Arial, sans-serif;
background: #fff;
color: #1e1e1e;
line-height: 1.6;
}
/* Utilities */
.sm-container {
max-width: 1300px;
margin: 0 auto;
padding: 20px 32px 60px;
width: 100%;
}
.sm-flex {
display: flex;
flex-wrap: wrap;
}
.sm-grid-2 {
display: grid;
grid-template-columns: 1fr 1fr;
gap: 40px;
}
.sm-grid-3 {
display: grid;
grid-template-columns: repeat(3, 1fr);
gap: 24px;
}
.sm-grid-4 {
display: grid;
grid-template-columns: repeat(4, 1fr);
gap: 20px;
}
/* Tabs */
.sm-tab-input {
display: none;
}
.sm-panel {
display: none;
}
#sm-tab-product:checked~.sm-tab-nav label[for=”sm-tab-product”],
#sm-tab-disclaimer:checked~.sm-tab-nav label[for=”sm-tab-disclaimer”] {
background: #F27444;
color: #fff;
border-color: #F27444;
box-shadow: 0 8px 20px rgba(242, 116, 68, 0.25);
}
#sm-tab-product:checked~.sm-product-panel {
display: block;
}
#sm-tab-disclaimer:checked~.sm-disclaimer-panel {
display: block;
}
/* FAQ */
.sm-faq summary::-webkit-details-marker {
display: none;
}
.sm-faq[open] .sm-plus {
transform: rotate(45deg);
}
/* Chips */
.sm-chip {
display: inline-block;
padding: 8px 16px;
border-radius: 999px;
background: #fff4ef;
border: 1px solid #ffd9cb;
color: #F27444;
font-weight: 600;
font-size: 0.9rem;
margin: 4px 6px 4px 0;
letter-spacing: 0.02em;
}
/* Cards & Hover */
.sm-card {
background: #fff;
border: 1px solid #f0e8e4;
border-radius: 28px;
padding: 28px;
transition: all 0.2s ease-in-out;
}
.sm-card:hover {
transform: translateY(-4px);
box-shadow: 0 20px 40px -12px rgba(0, 0, 0, 0.08);
border-color: #F27444;
}
.sm-card-glow {
background: linear-gradient(135deg, #fff 0%, #fff8f5 100%);
border: 1px solid #ffe1d6;
}
/* Specs Zebra */
.sm-spec-grid {
display: grid;
grid-template-columns: 1fr 1fr;
}
.sm-spec-item {
padding: 16px 24px;
border-bottom: 1px solid #f0e8e4;
background: #fff;
}
.sm-spec-item:nth-child(odd) {
background: #fcfaf9;
}
/* Responsive */
@media(max-width:768px) {
.sm-container {
padding: 20px 16px 40px;
}
.sm-grid-2,
.sm-grid-3,
.sm-grid-4 {
grid-template-columns: 1fr !important;
gap: 20px;
}
.sm-spec-grid {
grid-template-columns: 1fr;
}
.sm-tab {
width: 100% !important;
text-align: center !important;
}
.sm-hero-title {
font-size: 32px !important;
}
h2 {
font-size: 24px !important;
}
}
/* Misc */
.sm-tab {
font-size: 1rem;
padding: 12px 32px;
border-radius: 999px;
background: #fff;
border: 1px solid #e0d6d0;
color: #1e1e1e;
cursor: pointer;
font-weight: 600;
transition: all 0.2s;
user-select: none;
}
.sm-tab:hover {
background: #fff4ef;
border-color: #F27444;
}
.sm-hero-bg {
background: radial-gradient(ellipse at 70% 20%, rgba(242, 116, 68, 0.04) 0%, rgba(255, 255, 255, 0) 70%);
}
/* Reference list item hover */
.ref-item {
padding: 16px 20px;
background: #fff;
border-radius: 16px;
border: 1px solid #f0e8e4;
transition: all 0.2s ease-in-out;
}
.ref-item:hover {
border-color: #F27444;
box-shadow: 0 4px 12px rgba(242, 116, 68, 0.08);
}
.ref-item a {
color: #F27444;
font-weight: 700;
text-decoration: none;
}
.ref-item a:hover {
text-decoration: underline;
}
SaiyanMed Research Grade
CJC‑1295 (No DAC)
DPP‑IV‑resistant GHRH(1‑29) analog · research grade
Research‑grade CJC‑1295 (without the Drug Affinity Complex) is a synthetic 29‑amino‑acid analog of growth hormone‑releasing hormone (GHRH). It incorporates specific structural modifications that confer resistance to dipeptidyl‑peptidase‑IV (DPP‑IV), thereby extending its half‑life relative to unmodified GHRH(1‑29) while preserving a short, pulsatile pharmacokinetic profile. This formulation is widely referred to in research settings as Modified GRF (1‑29), although nomenclature may vary. Each vial is lyophilized, ≥99% HPLC pure, MS‑confirmed, and supported by publicly verifiable third-party COAs published in our Trust Center. For research use only — not for human or veterinary use.
≥99% HPLC
MS Confirmed
Third-Party COA
Lyophilized
10‑Vial Kit
Global Warehouse Fulfillment
GHRH Receptor Agonist
GHRHR · Class B GPCR
Designed for research models studying growth‑hormone‑axis pulsatility, amplitude modulation, and comparative pharmacology against other GHRH analogs.
29 AA
CAS 863288‑34‑0
RUO
Research Context
Pulsatile GH‑Amplitude Tool
CJC‑1295 (No DAC) is positioned for mechanistic research into GHRH‑receptor signaling and growth‑hormone‑axis amplitude modulation — without the sustained, non‑pulsatile elevation induced by the DAC formulation.
GHRHR Agonism
Pulsatile GH
DPP‑IV Resistant
What is CJC‑1295 (No DAC)?
CJC‑1295 (No DAC) is a synthetic 29‑amino‑acid analog of growth hormone‑releasing hormone (GHRH). The commercial designation “CJC‑1295 without DAC” is frequently aligned with what is termed Modified GRF (1‑29) in laboratory research, though these are not strictly standardized synonyms. The peptide incorporates DPP‑IV‑resistant modifications — often involving N‑terminal amino acid substitutions such as Aib² — which extend its half‑life to approximately 30 minutes (literature range 20–40 min). Importantly, it lacks the Drug Affinity Complex (DAC) that would otherwise bind to serum albumin and create a sustained‑release profile.
Receptor activation at the GHRH receptor (GHRHR) triggers the Gs‑adenylyl‑cyclase / cAMP / PKA / CREB cascade, resulting in a transient, amplitude‑enhanced growth hormone release without the sustained elevation seen with DAC‑conjugated analogs. This makes CJC‑1295 (No DAC) a valuable tool for studying pulsatile GH secretion, amplitude‑dependent signaling, and downstream IGF‑1 effects.
It is widely used in endocrine research, often in combination with GHSR‑1a agonists like ipamorelin, to explore synergistic pathways in growth‑hormone regulation.
🧪 Research Applications
①
Pulsatile GH Amplitude
Study amplitude modulation of GH pulses vs. native GHRH or sermorelin — higher pulse intensity without sustained elevation.
②
DPP‑IV Resistance
Characterize protease stability and extended half‑life (~30 min) compared to native GHRH and unmodified GHRH(1‑29).
③
GHRH‑R vs. GHSR‑1a Stacking
Combine with ipamorelin to investigate synergistic GHRH‑receptor and ghrelin‑receptor co‑activation.
④
vs. CJC‑1295 With DAC
Compare pulsatile (No DAC) vs. sustained (With DAC) GHRH agonism in metabolic and endocrine models.
⑤
IGF‑1 / Body Composition
Investigate GH‑mediated IGF‑1 production and downstream effects on body composition in research models.
⑥
PK / Stability Profiling
Assess half‑life, clearance, and receptor binding kinetics relative to other GHRH analogs.
📊 Quick Specs
Form: Lyophilized powder (white to off‑white)
Purity: ≥99% by HPLC
Identity: MS molecular‑weight confirmed
CAS Number (common database reference): 863288‑34‑0
Also Known As: GHRH(1‑29) analog; Modified GRF (1‑29) (research nomenclature); commercial designation: CJC‑1295 without DAC
Sequence Length: 29 amino acids
Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
Molecular Weight: ~3367.9 Da (free base)
Receptor Target: GHRH receptor (GHRHR, class B GPCR)
Modification: DPP‑IV‑resistant structure (e.g., N‑terminal modification); no DAC
Half‑Life: ~30 min (SC; literature range 20–40 min; pulsatile)
Peptide Type: Synthetic GHRH(1‑29) analog
COA: Third-party lab tested — publicly verifiable
Manufacture: Lyophilized & QC‑released in‑house
Storage: −20°C sealed | 2–8°C reconstituted
Shelf Life: 24 months unopened (lyophilized)
VERIFIED
Certificate of Analysis
Independent Third-Party Validation
Transparency is central to our quality assurance. Batches undergo orthogonal analytical testing by an independent third‑party analytical testing service. The resulting Certificate of Analysis (COA) details specific HPLC chromatograms and MS spectra for that lot. End‑users can cross‑validate the document online via the SaiyanMed Trust Center using the unique batch identifier printed on the vial label.
Batch‑specific documentation ensures full traceability for your laboratory records. Always confirm the batch reference matches the product vial before use.
📦 Storage & Handling
🧊 Storage
Lyophilized vials: store at −20°C, sealed, protected from light and moisture. After reconstitution: store at 2–8°C and use within 2–4 weeks (study‑defined stability window). Avoid repeated freeze‑thaw cycles. The modified amino acids confer improved stability compared to native GHRH, but standard precautions still apply. Do not use if the reconstituted solution is cloudy or contains visible particles.
💧 Reconstitution
Add 1–2 mL of sterile diluent (e.g., bacteriostatic water) slowly down the inside wall of the vial. Do not shake or vortex; swirl gently until fully dissolved. CJC‑1295 (No DAC) dissolves readily at room temperature to a clear, colorless solution. Prepare working dilutions according to your laboratory protocol.
🚚 Fulfillment & Transit Notice
Global logistics: To maintain structural integrity, lyophilized peptides are shipped in thermally insulated packaging. While in transit, the product remains stable at ambient temperatures for the typical 7–14 day window. Upon arrival, immediate refrigeration at −20°C is recommended.
Warehouse origin: We strategically ship from the nearest fulfillment center to reduce transit time. US orders are dispatched domestically (5–7 business days); international orders ship from our Asian logistics hub (estimated 7–14 business days).
Customs & duties: While we handle export documentation, import duties or customs inspections are standard procedures for research chemicals and remain the responsibility of the consignee. Delays due to customs are a normal part of international shipping and do not indicate a product issue.
Delays or holds: If your shipment exceeds the estimated window or is held in customs, contact us with your order reference. Our support team will intervene with tracking and carrier coordination, and where applicable, arrange a reshipment per our policy.
Damaged or incorrect items: Inspect your order immediately upon arrival. If a vial is damaged or an item is incorrect, contact us within the stated policy period with photos for prompt resolution.
⚠️
Research Use Only
This material is supplied only for qualified laboratory research and is not intended for human or veterinary use.
Research Use Only
Not for Human Consumption
SaiyanMed products are strictly for in vitro and in vivo laboratory research. They are not intended for diagnostic, therapeutic, medical, disease‑prevention, consumer health, or personal use.
All SaiyanMed products are supplied for laboratory, scientific, and research use only. They are not for human consumption, medical treatment, diagnosis, disease prevention, or veterinary use.
✅ Buyer Confirmation
✓ You are a qualified researcher or acting under the supervision of one.
✓ Products will only be used for legitimate research purposes.
✓ Products are not evaluated by the FDA or any regulatory authority for human use.
✓ You assume responsibility for legal compliance, proper handling, storage, and disposal.
No Warranty: Products are sold “as is,” with no express or implied warranties regarding efficacy, safety, or suitability. Results in research may vary. SaiyanMed is not responsible for outcomes, interpretations, or conclusions drawn from any studies conducted using these products.
🛡️ General Safety & Handling
🚫 Not for Human Use
These compounds are for research only. Any off‑label, personal, or clinical use is outside the intended scope.
🥽 PPE Required
Always use appropriate personal protective equipment, including gloves, lab coat, and eye protection.
🌡 Storage Compliance
Follow product‑specific storage conditions to maintain identity, purity, and biological activity.
🗑 Proper Disposal
Dispose of all materials according to institutional biosafety, chemical waste, and hazardous material protocols.
🧾 Verify Quality
Verify batch identity, MS confirmation, HPLC purity, and COA status before research use.
⚖ Legal Compliance
Researchers are responsible for lawful purchase, possession, storage, and use in their jurisdiction.
💬 Frequently Asked Questions
What is the difference between CJC‑1295 with DAC and without DAC?+
The “with DAC” version includes a Drug Affinity Complex that binds to serum albumin, extending its half‑life to several days and producing sustained GH elevation. The “No DAC” version has a short, pulsatile half‑life (~30 min) that more closely mimics natural GHRH pulses, resulting in intermittent GH release without the continuous elevation seen with the DAC‑conjugated form.
How does CJC‑1295 (No DAC) compare to sermorelin?+
Both are GHRH(1‑29) analogs, but CJC‑1295 (No DAC) has DPP‑IV‑resistant modifications, giving it a half‑life of approximately 30 minutes (literature range 20–40 min) compared to sermorelin’s ~10–15 minutes. This results in a higher amplitude GH pulse, making it a more potent tool for studying pulsatile GH release.
How is purity verified?+
Each production lot is subjected to quantitative HPLC (≥99% purity) and high‑resolution mass spectrometry for identity confirmation. A third-party COA is published for tested batches and is independently verifiable online via the batch‑specific identifier.
How should it be stored?+
Lyophilized vials should be kept at −20°C, away from light and moisture. After reconstitution with sterile diluent, store at 2–8°C and use within 2–4 weeks. Avoid repeated freeze‑thaw cycles.
Where does it ship from?+
Orders are dispatched from the nearest available warehouse – US domestic orders from our US fulfillment center, international orders from our Asian hub. Estimated delivery is 5–7 days for US and 7–14 days for global shipments, with tracking provided.
Is this intended for human use?+
No. This material is strictly for laboratory research use only and is not intended for human consumption, diagnosis, treatment, disease prevention, or any personal use. It is not a pharmaceutical product.
📚 References
The following references provide background biological and regulatory context for GHRH analogs. They are not specific pharmacokinetic or pharmacological data sources for CJC‑1295 (No DAC), but rather support the broader endocrine research framework.
Ionescu M, Frohman LA (2006):
Pulsatile secretion of growth hormone (GH) and its regulation by the hypothalamic‑pituitary‑GH axis. (Review of GHRH physiology and analog pharmacology.)
View at PubMed ↗
FDA (Drugs@FDA):
EGRIFTA® (tesamorelin) NDA 022505 – for regulatory context on GHRH analog class.
View at FDA ↗
Note on nomenclature: The commercial designation “CJC‑1295 (No DAC)” is commonly used in the research supply market. The peptide is often referred to as Modified GRF (1‑29) in laboratory settings. CAS numbers for this analog vary across databases; 863288‑34‑0 is a common identifier, but researchers should cross‑reference with batch‑specific analytical data (MS, HPLC) for definitive identification.





Reviews
There are no reviews yet.